Clearside Biomedical Announces Positive Topline Results from Pivotal Phase 3 Clinical Trial of CLS-TA Pharmaceutical Investing
U.S. FDA Accepts New Drug Application for Prucalopride for Chronic Idiopathic Constipation Pharmaceutical Investing
EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update Pharmaceutical Investing
Reata Pharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial and Operating Results Pharmaceutical Investing
Zosano Pharma Announces Issuance of New U.S. Patent Covering M207 as an Acute Treatment for Migraine Pharmaceutical Investing
